Maintenance Therapy of HMA in Favorable Risk AML Patients

Conditions: Acute Myeloid Leukemia Interventions: Drug: Hypomethylating agent, Azacitidine or Decitabine Sponsors: The First Affiliated Hospital of Soochow University Recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials